This product is a mouse monoclonal antibody that is specific for human GPC3. This antibody can be used in a variety of applications, such as ELISA, WB.
Figure 1 Flow cytometry analysis of five selected mouse hybridoma clones (YP6, YP7, YP8, YP9 and YP9.1) (solid lines) and 1G12, a control anti-GPC3 mAb (dotted lines, in the middle) using A431/G1 and Hep3B.
Filled peak: isotype control.
Phung, Y., Gao, W., Man, Y. G., Nagata, S., & Ho, M. (2012, September). High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening. In MAbs (Vol. 4, No. 5, pp. 592-599). Taylor & Francis.
Figure 2 ELISA analysis of five hybridoma clones on recombinant GPC3 proteins.
GPC3: recombinant GPC3-human Fc; GPC3ΔHS: recombinant GPC3 without HS; control: BSA. 1G12: a commercial anti-GPC3 mAb.
Phung, Y., Gao, W., Man, Y. G., Nagata, S., & Ho, M. (2012, September). High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening. In MAbs (Vol. 4, No. 5, pp. 592-599). Taylor & Francis.
Figure 3 western blot analysis of YP7 and YP9.
Thirty μg of whole cell lysates of HepG2, Hep3B, A431/G1 (A431.GPC3+) and A431 was loaded and probed with each hybridoma supernatant.
Phung, Y., Gao, W., Man, Y. G., Nagata, S., & Ho, M. (2012, September). High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening. In MAbs (Vol. 4, No. 5, pp. 592-599). Taylor & Francis.
Figure 4 Binding of immunotoxins on G1 cells.
Zhang, Y. F., & Ho, M. (2016). Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma. Scientific reports, 6(1), 1-11.
Figure 5 Cytotoxicity of immunotoxins on G1 cells. IT, immunotoxin.
The numbers in parentheses are EC50 values of immunotoxins in ng/ml.
Zhang, Y. F., & Ho, M. (2016). Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma. Scientific reports, 6(1), 1-11.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1563z | Mouse Anti-GPC3 Recombinant Antibody (clone 29F5) | WB, ELISA, FC, ICC, IF, IHC | Mouse IgG1 |
VS3-WK133 | Mouse Anti-GPC3 Recombinant Antibody (clone G3-C2) | WB, ELISA | Mouse IgG1 |
VS3-FY605 | Recombinant Mouse Anti-GPC3 Antibody (clone 2A2C3) | ELISA, WB, IHC, FC | Mouse IgG1 |
VS3-FY606 | Recombinant Mouse Anti-GPC3 Antibody (clone 2A2H1) | ELISA, WB, IHC, FC | Mouse IgG1 |
VS3-FY607 | Recombinant Mouse Anti-GPC3 Antibody (clone 2C7E9) | ELISA, WB, IHC, FC | Mouse IgG1 |
There are currently no Customer reviews or questions for FAMAB-0557WJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.